Neuropeptides and Alzheimer's Disease

M. M. Husain, C. B. Nemeroff

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Because of their putative roles as neurotransmitters, neuromodulators, and neuroregulators in the central nervous system, neuropeptides have been the focus of considerable research over the past two decades. There is evidence that alterations in the synaptic availability of particular neuropeptides occur in certain neuropsychiatric disorders, such as schizophrenia and affective disorders. Alzheimer's disease is the most common neurodegenerative disorder, affecting a sizable proportion of our aging population. Alzheimer's disease is characterized by the presence of neurofibrillary tangles and senile plaques in the central nervous system. Postmortem studies have provided evidence that several neuropeptide‐containing neurons are pathologically altered in this disorder. The purpose of this article is to describe recent advances in neuropeptide biology with a focus on the role of neuropeptides in the pathogenesis of Alzheimer's disease. 1990 The American Geriatrics Society

Original languageEnglish (US)
Pages (from-to)918-925
Number of pages8
JournalJournal of the American Geriatrics Society
Issue number8
StatePublished - Aug 1990

ASJC Scopus subject areas

  • Geriatrics and Gerontology


Dive into the research topics of 'Neuropeptides and Alzheimer's Disease'. Together they form a unique fingerprint.

Cite this